Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Psychoneuroendocrinology. 2018 Jun 30;97:47–58. doi: 10.1016/j.psyneuen.2018.06.024

Table 6.

Number and percentage (%) of replication-dependent histone peptides without (No) and with (Yes) acetylation post-translational modification (PTM) by genotype-treatment group and by histone cluster family.

Histone Genotype-treatmentb Genotype-treatment
cluster WT_ Sal WT_ BCG KO_ BCG Total % WT_ Sal WT_ BCG KO_ BCG Total %
Family member No PTM No PTM No PTM No PTM No PTM Yes PTM Yes PTM Yes PTM Yes PTM Yes PTM Total
Total Hist 1 4028 3258 5150 12436 98% 96 116 90 302 2% 12738
% Hist 1 83% 78% 84% 86% 85% 89%
Total Hist 2 727 803 822 2352 99% 9 14 7 30 1% 2382
% Hist 2 15% 19% 13% 8% 10% 7%
Total Hist 3 39 32 56 127 100 % 0 0 0 0 0% 127
% Hist 3 1% 1% 1% 0% 0% 0%
Hist 4 88 77 88 253 94% 6 6 4 16 6% 269
% Hist 4 2% 2% 1% 5% 4% 4%
Total 4882 4170 6116 15168 98% 111 136 101 348 2% 15516
a

Hist #: Histone # cluster

b

WT = wild type mice; KO = IDO1 KO mice; Sal = saline treatment; BCG = Bacillus Calmette–Guérin treatment.